Efficacy of intermittent empagliflozin supplementation on dietary self-management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24-week randomized controlled trial. Diabetes Obes Metab. 2019 Feb;21(2):303-311. doi: 10.1111/dom.13524.